Conference abstract · 14 May 2018
Conference abstractPublished 3 Oct 2018
Biomarker discovery facilitated by next generation sequencing
Mayo Clinic, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Radical improvement in cancer care will be accomplished by individualizing patient management via the integration of genomics and functional model systems. A process that uses comprehensive genomics to discover biomarkers will be presented and followed by a representative example. The hypothesis was that chromosomal rearrangements (CRs) could separate low-risk of progression (LRP) from an intermediate and high risk of progression (IHRP) prostate cancer (PCa). The number of abnormal junctions did not distinguish LRP from IHRP. Loci corresponding to genes implicated in PCa were more frequently altered in IHRP. Integrated analysis of CNVs and microarray data yielded six potential markers that were more frequently detected in the GP3 of a Gleason score of 7 (GS7) PCa compared to GP3 in a GS6 PCa. Five of those were cross-validated in an independent sample-set with statistically significant AUCs. Recent breakthroughs in immunotherapy and targeted therapies are now becoming cancer agnostic (i.e. NTRK inhibitors) arguing for a more individualized approach to patient care. A process that uses that a combination of comprehensive genomics with 3D organoid-type functional model systems to guide treatments will be presented followed by a representative example. We tested the hypothesis in a triple negative breast cancer (TNBC) patient with metastatic. Comprehensive genomic information derived from the patientâ??s tumor cells was integrated with the purpose of deciphering the activated molecular pathways in her tumor. The results of the genomic analysis were then used to functionally validate drug sensitivity and predict response to therapy in 3D micro cancer preclinical model systems grown from the patientâ??s tumor cells. The patient was subsequently treated with the recommended drug and showed a near complete response as observed by radiographic and blood-marker testing.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2017
Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma
Conference abstract · 5 Oct 2018
Next-generation sequencing and immunotherapy biomarkers: A step ahead in cancer treatment
Conference abstract · 28 Sep 2015
Next generation sequencing methodologies in identifying biomarkers and treatment options across cancers
Article · 26 Oct 2026
Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “George Vasmatzis”

